Chronic Pain Clinical Trial
Official title:
Study Protocol of a Single Case Methodology Experiement Exploring the Effectiveness and Feasibility of an Exposure-centered ACT Intervention for Chronic Pain Patients: A Pilot Study
Background: Chronic pain is a highly prevalent phenomenon with a large impact on the
individual's wellbeing. Acceptance and Commitment Therapy (ACT) can be used to help patients
relate to chronic pain in a way that helps improve their quality of life. This paper
introduces an ACT protocol specific to chronic pain patients: ACT- Exposure and Perspective
Taking (ACT-EPT). Aspects specific to this therapy are the focus on exposure as a means to
elicit behavioural and emotional change regarding pain experience and it's format as a
compact individual therapy.
Objectives: Investigators conduct a single case experimental study (ABA design) with a
multiple baseline design, aimed at assessing the effectiveness of the experimental ACT-EPT
protocol (phase B) compared to usual care (phase A) in individual chronic pain patients.
Outcomes include the increase of participation in daily life and health related quality of
life, measured with the Short Form-12 (SF-12). Quantitative results will be combined with
qualitative results from interviews in a mixed methods design.
Participants: Five adults with chronic pain referred to a rehabilitation centre (≥18 years
old).
Methods: Phases A and B together take 16 weeks for each participant, during which weekly
quantitative measurements will be taken. The length of the first phase A will be randomised.
The intervention (phase B) consists of weekly ACT-EPT sessions with a maximum of 3 sessions
of approximately 90 minutes each. Individual interviews will take place after the last
quantitative measurements. These focus on two topics: psychological processes of change and
evaluating the intervention.
Rationale: Chronic pain is a phenomenon with a large impact on the individual's wellbeing and
is a problem with a large global burden of disease, with a prevalence of 19 to 20% in
European adults and an annual cost of €200 billion in Europe. Apart from causing physical
suffering, chronic pain can lead to depression, suicidal thoughts and disrupted social
relationships and can cause impairments in everyday life tasks and activities. Despite the
seriousness of chronic pain, not all chronic pain patients receive adequate treatment. One
cognitive behavioral therapy treatment which is used in the Netherlands for chronic pain
patients is the Acceptance and Commitment Therapy (ACT). However, the way in which this
therapy is delivered in the Netherlands tends to take many sessions. It therefore seems
attractive to investigate a short version of this protocol, which was developed in Sweden.
This short version, ACT-EPT, is already being used in the Netherlands on a small scale but
its effects have not yet been studied. The current paper proposes a pilot study with an
innovative N-of-1 design to investigate this therapy's effectiveness.
Objective: Investigating the effectiveness of an experimental protocol of Acceptance and
Commitment Therapy-Exposure & Perspective Taking (ACT-EPT) compared to usual care in
individual chronic pain patients on the increase of their participation in daily life and
health related quality of life, as measured with the SF-12 in a study with a single case
experimental methodology.
Study design: The randomized n=1 study combines a quantitative and a consecutive qualitative
part (mixed methods). Each participant receives the intervention and serves as his or her own
control in an AB design. In phase A, all participants continue the care they already received
which will be recorded as their care as usual. At a random moment, phase A will end and
participants will start their intervention, thus entering phase B. This study randomizes
participants on the duration of phase A, which means that the lengths of phases A and B
differs among participants. The total study period (A+B) over which participants will receive
weekly measurements is the same for all participants (16 weeks). Results will be presented on
an individual basis according to the single case experimental methodology. In the last week
of the total period, participants will be invited for an interview with a researcher
focussing on their experience living with chronic pain and to evaluate the intervention. This
interview will take place in the participants' own environment. Methodological details of all
aspects of the design will be explained further in the protocol.
Study population: Chronic pain patients of 18 years or older referred the Rehabilitation
Centre Winnock Zorg in Heerlen or Arnhem for treatment (n=5).
Intervention: The ACT-EPT treatment protocol is a type of acceptance-based cognitive
behavioral therapy, aimed to increase patients' participation by improving their level of
coping with chronic pain. The therapy takes between one and three sessions of about an hour
and a half each.
Main study parameters/endpoints: The primary outcome measure of this study is the SF-12.
Secondary outcome measures are the AAQ-II-P, PIPS, PSK, PDI, NPRS , IPA, FFMQ-SF and the ELS.
The PSK will only be used for clinical purposes.
Nature and extent of the burden and risks associated with participation, benefit and group
relatedness: No risks are associated with this study. The load for the participants consists
of the weekly filling out of a limited amount of questionnaires and the participation in a
one hour interview. The number of questionnaires that patients are asked to fill out differs
per week, with a lowest load per week of 8 minutes and the highest load at baseline of 55
minutes. The total time taken to fill out all questionnaires over the 16 week period is 6
hours and 55 minutes, with an average of 26 minutes per week. Detailed information can be
found in the questionnaires table in the protocol. The intervention takes between one and
three sessions of about an hour and a half each, and is given in the rehabilitation centre.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
| Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
| Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
| Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
| Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
| Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
| Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
| Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
| Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
| Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
| Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
| Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
| Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
| Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
| Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
| Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
| Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
| Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
| Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|